Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.

Saima Aslam, Paolo Grossi, Kelly H Schlendorf, Are M Holm, Ann E Woolley, Emily Blumberg, Mandeep R Mehra, working group members

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2020 May

filter terms:

The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus-positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years. Copyright © 2020 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Citation

Saima Aslam, Paolo Grossi, Kelly H Schlendorf, Are M Holm, Ann E Woolley, Emily Blumberg, Mandeep R Mehra, working group members. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2020 May;39(5):418-432